Saturday, 17 October 2026European Markets

AXACTOR Stock Over 21% Up In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of AXACTOR (Oslo Børs Benchmark Index_GI: ACR.OL) jumped by a staggering 21.22% in 10 sessions from kr5.89 to kr7.14 at 13:28 EST on Monday, following the last session's downward trend. Oslo Børs Benchmark Index_GI is rising 0.91% to kr1,237.83, following the last session's downward trend.

About AXACTOR

Axactor ASA, through its subsidiaries, operates as a debt management company in Sweden, Finland, Germany, Italy, Norway, and Spain. It operates through three segments: Non-performing Loans, Real estate Owned, and Third-Party Collection. The company offers debt collection services, including amicable and legal collection; debt purchase; and accounts receivable management services. It is also involved in the acquisition and collection of non-performing loan portfolios; and investment of real estate assets held for sale. Axactor ASA was founded in 2015 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, AXACTOR has a trailing twelve months EPS of kr-1.17.

Volatility

AXACTOR's last week, last month's, and last quarter's current intraday variation average was 0.15%, 0.99%, and 1.61%.

AXACTOR's highest amplitude of average volatility was 1.86% (last week), 2.06% (last month), and 1.61% (last quarter).

More news about AXACTOR (ACR.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com